Lodo Therapeutics Corp.

Oct 27, 2020

Lodo Therapeutics Achieves Second Preclinical Milestone In Its Strategic Collaboration With Genentech

Sep 03, 2020

Lodo Therapeutics Acquires Hibiskus BioPharma And Licenses Rights To Novel Proteasome Inhibitors

Jul 01, 2020

Lodo Therapeutics Strengthens R&D Leadership With Expanded Executive Roles And Addition Of Scientific Advisory Board

Jun 01, 2020

Lodo Therapeutics to Present at Jefferies Virtual Healthcare Conference

May 06, 2020

Lodo Therapeutics Appoints Donald Marvin Executive Vice President And Chief Financial Officer